Predicting Corticosteroid-Free Biologic Remission with Vedolizumab in Crohn’s Disease

BACKGROUND AND AIMS: Vedolizumab (VDZ) is effective for Crohn’s disease (CD) but costly and is slow to produce remission. Early knowledge of whether vedolizumab is likely to succeed is valuable for physicians, patients, and insurers. METHODS: Phase 3 clinical trial data on VZD for CD were used to pr...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Inflamm Bowel Dis
Main Authors: Waljee, Akbar K, Liu, Boang, Sauder, Kay, Zhu, Ji, Govani, Shail M, Stidham, Ryan W, Higgins, Peter D R
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2018
Fag:
Future Directions
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6231370/
https://ncbi.nlm.nih.gov/pubmed/29668915
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ibd/izy031
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker